Informação sobre produto
TAK-700 is a novel nonsteroidal antiandrogen that binds to the endothelin-A receptor. It has been shown to reduce the risk of prostate cancer, and also possess anti-inflammatory properties. TAK-700 was shown to inhibit the growth of granulosa cells in vitro and in vivo, which may be due to its ability to bind to and inhibit the activity of endothelin-A receptors. TAK-700 also inhibits enzyme activities such as polymerase chain reaction (PCR) and protein synthesis in prostate cancer cells. TAK-700 is being investigated for use in treating infectious diseases, such as hepatitis C virus infections, as well as other types of cancers that are associated with glucocorticoid receptor activation. The drug has been shown not to have any significant effects on adrenal function when administered at therapeutic doses.
Propriedades químicas
Consulta técnica sobre: 3D-BSA21918 TAK-700 (Orteronel)
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
